REVIEW
|
doi:10.20944/preprints202312.0917.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
Dorzagliatin; TTP399; glucokinase activator; Type 2 Diabetes; clinical trials; safety; efficacy
Online: 13 December 2023 (04:55:36 CET)